Normal cells, but not cancer cells, survive severe Plk1 depletion

Molecular and Cellular Biology
Xiaoqi LiuRaymond L Erikson

Abstract

We previously reported the phenotype of depletion of polo-like kinase 1 (Plk1) using RNA interference (RNAi) and showed that p53 is stabilized in Plk1-depleted cancer cells. In this study, we further analyzed the Plk1 depletion-induced phenotype in both cancer cells and primary cells. The vector-based RNAi approach was used to evaluate the role of the p53 pathway in Plk1 depletion-induced apoptosis in cancer cells with different p53 backgrounds. Although DNA damage and cell death can occur independently of p53, p53-deficient cancer cells were much more sensitive to Plk1 depletion than cancer cells with functional p53. Next, the lentivirus-based RNAi approach was used to generate a series of Plk1 hypomorphs. In HeLa cells, two weak hypomorphs showed only slight G2/M arrest, a medium hypomorph arrested with 4N DNA content, followed later by apoptosis, and a strong Plk1 hypomorph underwent serious mitotic catastrophe. In well-synchronized HeLa cells, a medium level of Plk1 depletion caused a 2-h delay of mitotic progression, and a high degree of Plk1 depletion significantly delayed mitotic entry and completely blocked cells at mitosis. In striking contrast, normal hTERT-RPE1 and MCF10A cells were much less sensitive to Plk1 deplet...Continue Reading

References

May 19, 1997·Biochemical and Biophysical Research Communications·M R SmithD K Ferris
Jun 25, 1998·Molecular and Cellular Biology·Y W QianJ L Maller
Feb 26, 1999·Science·J KarlsederT de Lange
Feb 5, 2000·JAMA : the Journal of the American Medical Association·K StrebhardtR Kaufmann
Dec 5, 2000·International Journal of Cancer. Journal International Du Cancer·R KnechtK Strebhardt
May 16, 2001·The Journal of Cell Biology·M M DonaldsonD M Glover
Jun 22, 2002·Proceedings of the National Academy of Sciences of the United States of America·Xiaoqi Liu, Raymond L Erikson
Dec 19, 2002·Journal of the National Cancer Institute·Birgit Spänkuch-SchmittKlaus Strebhardt
Jan 16, 2003·Oncogene·Robert ElezStefan Zeuzem
Mar 22, 2003·RNA·Sheila A StewartCarl D Novina
May 7, 2003·Proceedings of the National Academy of Sciences of the United States of America·Xiaoqi Liu, Raymond L Erikson
Mar 16, 2004·The Journal of Biological Chemistry·Patricia S KhoQiang Yu
Mar 17, 2004·The Journal of Biological Chemistry·Kiyohiro AndoAkira Nakagawara
Jun 3, 2004·Journal of the National Cancer Institute·Birgit SpänkuchKlaus Strebhardt
Jun 3, 2004·Nature Reviews. Molecular Cell Biology·Francis A BarrErich A Nigg
Oct 2, 2004·Current Biology : CB·Izabela SumaraJan-Michael Peters
Jan 11, 2005·Oncogene·Frank EckerdtKlaus Strebhardt
Jan 11, 2005·Oncogene·Noriyuki TakaiIsao Miyakawa
Mar 16, 2005·Cancer Cell·Kiranmai GumireddyE Premkumar Reddy
Jun 1, 2005·Molecular and Cellular Biology·Xiaoqi LiuRaymond L Erikson

❮ Previous
Next ❯

Citations

Aug 3, 2011·Molecules and Cells·Ravichandran N MuruganJeong Kyu Bang
Oct 13, 2009·Molecular Biology Reports·Xiaoming YangXiaoqi Liu
Jun 23, 2006·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Marcos Malumbres
Mar 17, 2012·ACS Chemical Biology·Mark E BurkardPrasad V Jallepalli
Nov 11, 2011·Journal of Medicinal Chemistry·Matthew O DuffeyNatalie D'Amore
Apr 22, 2006·Nature Methods·Beate NeumannJan Ellenberg
Nov 26, 2010·Nature Reviews. Cancer·Susanne M A LensRené H Medema
Jul 2, 2009·Nature Reviews. Drug Discovery·Silvia Lapenna, Antonio Giordano
Jul 31, 2010·Nature Reviews. Drug Discovery·Klaus Strebhardt
Oct 22, 2008·Oncogene·D C Altieri
Aug 27, 2009·Proceedings of the National Academy of Sciences of the United States of America·Takumi MatsumotoPaul M Hwang
May 29, 2009·The Journal of Biological Chemistry·Xiaoming YangXiaoqi Liu
Mar 22, 2008·The Journal of Biological Chemistry·Mayilvahanan Shanmugam, Nouria Hernandez
Jul 16, 2008·The Journal of Biological Chemistry·Zhao-Qiu WuXiaoqi Liu
Jun 4, 2011·Anti-cancer Drugs·Kristina SpaniolClaudia Lanvers-Kaminsky
Nov 30, 2006·Current Opinion in Oncology·Alex Gaither, Vadim Iourgenko
Aug 6, 2008·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Robert A EllingMichael J Romanowski
Aug 8, 2012·Molecular and Cellular Biology·Kathryn M CappellAngelique W Whitehurst
Mar 18, 2009·Molecular and Cellular Biology·Hyungshin Yim, Raymond L Erikson
Mar 25, 2009·Molecular and Cellular Biology·Kazuhiro KishiMichael B Yaffe
Sep 29, 2011·Molecular and Cellular Biology·Bing SongXiaoqi Liu
Nov 29, 2012·Molecular Cancer Therapeutics·Bing SongXiaoqi Liu
Sep 3, 2011·Journal of Clinical Bioinformatics·Eri KawataTaira Maekawa
Jan 16, 2009·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Hiroshi HiraiHidehito Kotani
Sep 2, 2010·PloS One·Regina Berretta, Pablo Moscato
Jul 25, 2012·World Journal of Gastroenterology : WJG·Wei Chuen MokSeng Gee Lim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis